• Phase 1/2 Trial Begins on ONCOS-102, Imfinzi Combination in Advanced Ovarian, Colorectal Cancers
  • Lynparza Maintenance Delays Disease Progression in Advanced Ovarian Cancer, Phase 3 Trial Shows
  • Artificial Ovary Might Help Women Conceive After Ovarian Cancer Treatment, Study Reports
  • Kazia’s Cantrixil Shows Signs of Effectiveness in Advanced Ovarian Cancer Trial
  • Basilea Begins Phase 2a Expansion Trial Testing BAL101553 in Ovarian, Brain Cancers
  • Anti-cancer Protein, Once Reactivated, Seen to Target Ovarian Cancer Cells in Early Study
  • AIVITA Advances Phase 2 Clinical Trial for Ovarian Cancer Vaccine
  • Mirvetuximab Soravtansine Given FDA Fast Track Designation for Ovarian Cancer Treatment
  • Splash Begins Expansion Phase of SPL-108 Trial for Ovarian Cancer Patients
  • A Second Surgery Can Improve Survival for Women with Recurring Ovarian Cancer, Study Shows
  • Zejula Added to UK’s Cancer Drugs Fund for Recurrent, Platinum-sensitive Ovarian Cancer
  • FDA Approves Avastin in Combination with Chemotherapy as Treatment for Advanced Ovarian Cancers